We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.

Suitcase

Interruption to Supply of Quadrivalent Meningococcal Vaccine (ACWY Vax®)

01 August 2013

GlaxoSmithKline (GSK) has announced that ACWY Vax® (capsular polysaccharide) quadrivalent meningococcal vaccine, is due to go out of stock in September 2013, and will not be back in stock before January 2014.

Both quadrivalent conjugate meningococcal vaccines are in normal supply:

  • Menveo® (Novartis Vaccines) - SPC
  • Nimenrix® (GSK) - SPC

The JCVI recommends that in children and adults, ACWY conjugate vaccine should be used in preference to the polysaccharide vaccine to reduce the risk of hyporesponsiveness and to provide better protection.